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Abstract
Background: Smartphone apps can be a tool to facilitate independent medication management among persons with developmental
disabilities. At present, multiple medication management apps exist in the market, but only 1 has been specifically designed for
persons with developmental disabilities. Before initiating further app development targeting this population, input from stakeholders
including persons with developmental disabilities, caregivers, and professionals regarding the most preferred features should be
obtained.
Objective: The aim of this study was to identify medication management app features that are suitable to promote independence
in the medication management process by young adults with developmental disabilities using a Delphi consensus method.
Methods: A compilation of medication management app features was performed by searching the iTunes App Store, United
States, in February 2016, using the following terms: adherence, medication, medication management, medication list, and
medication reminder. After identifying features within the retrieved apps, a final list of 42 features grouped into 4 modules
(medication list, medication reminder, medication administration record, and additional features) was included in a questionnaire
for expert consensus rating. A total of 52 experts in developmental disabilities, including persons with developmental disabilities,
caregivers, and professionals, were invited to participate in a 3-round Delphi technique. The purpose was to obtain consensus on
features that are preferred and suitable to promote independence in the medication management process among persons with
developmental disabilities. Consensus for the first, second, and third rounds was defined as ≥90%, ≥80%, and ≥75% agreement,
respectively.
Results: A total of 75 responses were received over the 3 Delphi rounds—30 in the first round, 24 in the second round, and 21
in the third round. At the end of the third round, cumulative consensus was achieved for 60% (12/20) items in the medication list
module, 100% (3/3) in the medication reminder module, 67% (2/3) in the medication administration record module, and 63%
(10/16) in the additional features module. In addition to the medication list, medication reminder, and medication administration
record features, experts selected the following top 3 most important additional features: automatic refills through pharmacies;
ability to share medication information from the app with providers; and ability to share medication information from the app
with family, friends, and caregivers. The top 3 least important features included a link to an official drug information source,
privacy settings and password protection, and prescription refill reminders.
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Conclusions: Although several mobile apps for medication management exist, few are specifically designed to support persons
with developmental disabilities in the complex medication management process. Of the 42 different features assessed, 64%
(27/42) achieved consensus for inclusion in a future medication management app. This study provides information on the features
of a medication management app that are most important to persons with developmental disabilities, caregivers, and professionals.
(JMIR Mhealth Uhealth 2018;6(5):e129)  doi: 10.2196/mhealth.9527
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Introduction
Background
Developmental disabilities (DDs) is a term encompassing a
range of disorders that are usually present at birth, last
throughout the life span, and negatively affect the course of
development of an individual at physical, intellectual, or
emotional levels [1]. In the United States, the prevalence of any
DD among children aged 3 to 17 years increased from 5.8% to
7.0% between 2014 to 2016 [2]. With improved life expectancy
[3], adolescents and adults who have DDs naturally develop
several chronic comorbidities over time [4], in addition to those
intrinsically associated with their disability. People who have
DDs are 2.5 times more likely to develop health problems,
particularly neurological and psychological, compared with
those who do not have a disability [5]. The increased risk for
health problems has been verified from a young age, with
adolescents who have disabilities displaying an increased risk
to develop cardio-metabolic syndrome, cardiovascular disease,
osteoporosis, and malignant diseases compared with their
counterparts without a disability [6].
As a result of a high burden of diseases [7-9], polypharmacy,
whose definition may vary across studies but most frequently
denotes the use of 5 or more medications [10], is frequent among
this population [11-14] and nonadherence can be an issue [15].
A study in primary care in the Netherlands revealed that 75%
of people with DDs received medication compared with 59%
individuals in the matched control group [16]. Data from
Australia showed that polypharmacy (use of 5 or more
medications) was highly prevalent and increased with age,
affecting over 50% of individuals with a disability in the age
group of 40 to 59 years [14]. Psychotropic medications are the
most commonly prescribed class of drugs with reported use of
over one-third of subjects enrolled in 2 different studies [5,13].
Despite high health care needs in this population, significant
disparities in health and medical care utilization have
consistently been reported [17,18].
Persons with DDs may live with their family (71%) or in a group
home (13%) and often rely on caregivers for the performance
of instrumental activities of daily living [19]. One such activity
is medication management which involves several steps,
including obtaining prescriptions from a physician, acquiring
medications from a pharmacy, storing/taking/administering
medications, monitoring for adverse and intended effects, and
refilling medications [20]. Caregivers, with a range of medical
knowledge and education levels, are usually required to be
involved in each step of the medication use process [21], often
encountering challenges in this multistep process [20]. Over
the last decade, more emphasis has been placed on increasing
the autonomy of people who have DDs, but the literature
suggests that there is still considerable work to be done [22].
Technology is on the rise as a tool to promote independence in
many areas including mobility, hearing and vision,
communication, independent living, and computer use [23].
Existing and new technology can be used to empower persons
with DDs to manage their own health issues during the transition
to young adulthood [24]. The use of smartphone apps can be
one strategy to support young adults who are transitioning to a
state of independence to manage medications on their own. A
2016 survey assessing smartphone use among persons with DDs
revealed that little difference in ownership rates between this
population and the general population existed and that the use
of smartphones for text messaging, emailing, using the Internet
and social media, and using mobile apps increased among both
groups [25].
Medication Management Apps
At present, there are hundreds of medication management apps
in the market, some designed to manage all medications [26]
and others targeting specific disease states [27-32]. Medication
management apps in the first group most often comprise basic
features including keeping a medication list and sending
reminders for medication taking, and less frequently, more
advanced features such as the ability to track missed doses,
exporting data for provider analysis, refill reminders, or
managing multiple patient profiles [26,33]. Apps in the second
group usually include features to monitor specific
self-management activities or clinical parameters that are
characteristic of different disease states [27]. Even though the
evidence linking the use of apps to outcomes is sparse, 1 study
showed that the use of an app positively impacted glycemic
control and self-management in patients with diabetes [34].
With regard to apps specifically targeting persons with a DD,
Dicianno and colleagues [35-37] developed an integrated system
to support self-management of several health-related activities
among individuals with spina bifida [38], which showed
improvements in self-management abilities [35]. The interactive
Mobile Health and Rehabilitation (iMHere) system comprises
6 smartphone modules providing reminders to individuals to
take their medications, perform their catheterization and bowel
management programs, examine their skin, complete a survey
assessing depressive symptoms, and send and receive messages
to and from the clinician. The medications (MyMeds) module,
in addition to sending reminders, includes a list of all the
medications taken by the user along with a photo and
description, tracks whether medications were taken in response
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to reminders sent, and includes the pharmacy contact
information to facilitate refill requests [38]. The iMHere system
has 2-way communication between patients and providers and
allows providers to remotely monitor adherence or address any
problems related with medication management via a secure
portal based on information provided by the user.
Patient-centered technologic support such as iMHere is critical
to support persons with DDs in every step of the medication
management process.
Objectives
Previous assessments of medication management apps
highlighted their low quality [31,33,39] and showed that not a
single app combines all the desirable features [33]. Before
initiating any app development process, input from stakeholders
including persons with DDs, caregivers, and professionals
regarding the most preferred features for this population should
be obtained. Therefore, the aim of this study was to identify
medication management app features that are suitable to promote
independence in the medication management process by young
adults who have DDs using a Delphi consensus method.
Methods
Development of the Initial Questionnaire
To identify medication management app features to be included
in the Delphi questionnaire, a sample of medication management
apps was reviewed. The works by Haase et al [40], Dinh et al
[41], and Heldenbrand et al [42] served as a starting point to
identify medication management app features. Furthermore, an
apps search was conducted in Apple’s iTunes App Store, United
States, in February 2016 to identify other relevant features using
the following terms: adherence, medication, medication
management, medication list, and medication reminder.
Duplicate apps identified from the different search strategies
were eliminated. Apps were included if they had any of the
following features: medication list, dose reminders, dose
documentation, or refill-assistance mechanisms. Apps designed
for disease management but that did not include any features
related with the medication management process were excluded.
A subset of apps of each search strategy employed was
reviewed, with a total of 39 apps ultimately being reviewed, to
identify a list of app features (Figure 1).
Features of the apps reviewed were identified and summarized
by 2 independent researchers (AF and TMS) based on the
description included in the App Store and personal experience
with the app after downloading and exploring its content and
features. The common features identified across the apps, and
that served as the basis for the questionnaire development,
included the following: medication list, medication reminder,
and medication administration report (including recording of
medication taking). Additional features identified across the
apps included prescription refill reminders; automatic pharmacy
refill mechanisms; barcode scan to enter medications; use of a
drug directory to enter new medications; ability to take a picture
of the pill being added; indication of missed doses; overdose
warnings; link to an official drug information source providing
information about the disease and the medication; ability to
export a file with medication taking data; record of vital signs
home monitoring (eg, blood pressure, blood glucose); record
of side effects; record of drug allergies; drug interaction checker;
scan health documents and upload them to the app; ability to
share medication information through the app (family, caregiver,
health care provider); notification of caregiver if drug not taken;
emergency contacts list; doctor name; doctor appointment
reminder; pharmacy name; pharmacy locator; and gamification
with rewards for users who adhere to their medication.
After identifying the list of medication app features, the research
team evaluated and weighed the inclusion of each of these
features in the final questionnaire, as well as the flow,
organization, and format of the questions. The final version of
the questionnaire (Multimedia Appendix 1) was organized into
4 modules that included (1) the medication list, (2) the
medication reminder, (3) the medication administration record,
and (4) additional features. Screenshots were selected from
existing apps and chosen to illustrate different information
presentation formats in the medication list, medication reminder,
and medication administration record features. Experts were
asked to rank 4 different screenshots per module, from most
preferred to least preferred, based on design and visual appeal
of the medication list, medication reminder, and medication
administration record features. The answer format was a
drag-and-drop list. Experts were then asked to rank the
importance or essentiality of various specific features within
the medication list, the medication reminder, and the medication
administration record on a Likert scale (not important or not
essential, less important or less essential, important or essential,
and very important or very essential). For example, experts were
asked to rank the importance of including specific medication,
prescription, and pharmacy and prescriber information in the
medication list feature. Module 4 presented a list of additional
features identified from the reviewed apps and asked experts to
rank their importance or essentiality on the same Likert scale.
Furthermore, participants were asked to select the 3 most
important and 3 least important additional features for inclusion
in an app specifically designed for this population. The final
portion of each of the 4 modules asked experts to provide
comments on the features presented or suggest additional
features not included in the initial questionnaire (free text
response).
Before recruitment was initiated, the questionnaire was piloted
with 3 individuals not directly associated with the research who
provided feedback about the clarity of the wording and
instructions, the answering format, and the flow of the questions
in a think aloud fashion. The survey took about 15 min to
complete.
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Figure 1. Flowchart of app search strategy and retrieval.
Selection and Recruitment of the Delphi Panel
A 3-round Delphi technique was used to gather consensus about
medication management app features that would be suitable to
assist young adults with DDs to independently manage their
medications. The Delphi method utilizes a panel of experts in
a field to establish consensus regarding a certain topic, with the
ideal number of experts being between 15 and 30 [43]. In this
study, a convenience sample of experts including persons with
a DD, caregivers, researchers, and professionals who were
familiar with the challenges and needs of persons with DDs was
gathered to provide their insight on the best features to include
in a future app designed specifically for this population and
their caregivers. Experts were recruited from 2 sources: (1) the
United Cerebral Palsy of Detroit Assistive Technology
conference that took place in Detroit (MI) in May 2016 (n=25)
and (2) the Technology Increasing knowledge: Technology
Optimizing Choice (TIKTOC) Rehabilitation Engineering
Research Center (RERC) Advisory Board and their mailing list
(n=27). TIKTOC is a collaboration of clinicians and researchers
at the University of Michigan whose mission is to develop and
implement technology to optimize and support the
self-management of personal health care and independence of
individuals with physical, cognitive, and neuro DDs. Attendees
of the United Cerebral Palsy of Detroit Assistive Technology
conference provided their names and email addresses voluntarily
to be part of the Delphi panel.
Experts were invited via an email, which included a link to the
anonymous questionnaire on Qualtrics. The invitation
encouraged experts to participate in all 3 rounds; however, they
were not excluded from participating in a round if they missed
the previous round(s). Participants were also able to make
comments and suggest additional features which were reviewed
by the research team at the end of each round, with relevant
items being included in subsequent rounds. Each Delphi round
lasted 1 week and, in-between rounds, we allowed 1 week before
rolling out the following round to minimize respondent fatigue.
The first round occurred between July 14 to 22, 2016; the second
between July 28 to Aug 4, 2016; and the third between Aug 12
to 19, 2016. E-mail reminders were sent 3 days before the
closing of each round to increase response rates. The process
ensured anonymity of respondents at each round, and the number
of individuals responding per round was noted. This study was
approved as exempt by the University of Michigan Institutional
Review Board (HUM00113908).
Consensus Criteria and Data Analyses
Consensus criteria were established based on a progressive
filtering process, with higher consensus requirements for the
first Delphi round and progressively lower consensus for
subsequent rounds—≥90%, ≥80%, and ≥75% agreement for
the first, second, and third rounds, respectively. Items achieving
consensus in each round were removed from the following
rounds and not scored again.
For the screenshot ranking-type questions, consensus was
calculated by assigning each screenshot a scaled score based
on whether it was chosen as the first, second, third, or fourth
option. Specifically, for a given screenshot option, we multiplied
the number of experts by 1, 2, 3, or 4 (1=most preferred, 4=least
preferred) according to how screenshots were ranked, creating
a score for each screenshot. Lower scores indicated higher
preference for a screenshot based on design and visual appeal.
For the Likert scale-type questions, consensus was calculated
based on the percentage of positive versus negative responses
for each feature, with positive being the sum of the percentage
of experts that selected both important and very important or
essential and very essential and negative being the sum of the
percentage of experts that selected both not important and less
important or not essential and less essential.
Descriptive statistics (percentages) were calculated to rate
consensus obtained for each feature in the 3 Delphi rounds and
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to determine the 3 most and 3 least important additional features
that should and should not, respectively, be included in a future
app.
Results
A total of 75 responses were received over the 3 Delphi
rounds—30 in the first, 24 in the second, and 21 in the third
round. Similar proportions of persons with disabilities and
caregivers participated in the study, but most respondents were
either researchers or professionals with an interest in DDs. Most
respondents were female, with extensive experience and
knowledge regarding DDs. Additional respondent characteristics
are outlined in Table 1.
Table 1. Characteristics of respondents of each of the 3 Delphi rounds.
Round 3 (n=21)Round 2 (n=24)Round 1 (n=30)Demographic characteristic
Age (years)
53.4 (19.6)49.1 (18.8)52.6 (17.1)Mean (SD)
9710Missing responses, n
Gender
10 (77)9 (50)13 (59)Female, n (%)
868Missing responses, n
Rolea
1 (7)3 (16)4 (17)Person with a disability, n (%)
03 (16)4 (17)Family caregiver for a person with a disability, n (%)
6 (43)8 (42)10 (44)Researcher with an interest in DDsb, n (%)
8 (57)11 (58)13 (57)Professional with an interest in DDs, n (%)
1 (7)1 (5)2 (9)Other, n (%)
757Missing responses, n
Level of experience and knowledge regarding persons with disabilities
8 (57)11 (58)14 (61)Extensive, n (%)
3 (21)6 (32)8 (35)Some, n (%)
3 (21)2 (11)1 (4.3)Limited, n (%)
757Missing responses, n
Disabilities individuals had direct experience witha
6 (46)11 (65)12 (55)Autism spectrum disorders, n (%)
8 (62)12 (71)16 (73)Cerebral palsy, n (%)
5 (39)11 (65)13 (60)Down syndrome, n (%)
2 (15)5 (29)8 (36)Fetal alcohol syndrome, n (%)
2 (15)4 (24)5 (23)Fragile X, n (%)
2 (15)2 (12)8 (36)Prader-Willi syndrome, n (%)
5 (39)6 (35)10 (46)Spina bifida
9 (69)14 (82)14 (64)Spinal cord injury, n (%)
2 (15)3 (18)6 (27)Williams syndrome, n (%)
3 (23)6 (35)11 (50)Otherc, n (%)
878Missing responses, n
aSum is >100% because participants selected more than 1 option.
bDDs: developmental disabilities.
cIncludes amyotrophic lateral sclerosis, brachial plexus injury, brain injury (traumatic and acquired), Charcot-Marie-Tooth disease, dyslexia, mechanically
ventilated patients, muscular dystrophy, other cognitive impairments, other genetic syndromes, Parkinson disease, and sensory-learning-injury.
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Module 1: Medication List
Of the 4 screenshots presenting different designs for the
medication list, option B (133 points) was the most preferred
among experts, but no consensus was achieved as to the best
way to present the information. The distribution of experts
selecting options C (145 points), D (146 points), and A (166
points) was very similar (Figure 2).
Of the 20 items assessed to be incorporated in the medication
list feature of a medication management app, consensus was
achieved for 12 (60%) throughout the 3 rounds (Multimedia
Appendix 2). In the first round, consensus (≥90% agreement)
was reached for the inclusion of instructions on how to take the
medicine and quantity of the medicine to be taken. Round 2
resulted in consensus (≥80% agreement) on dosage, indication,
number of prescription refills remaining, pharmacy phone
number, drug directory to help populate medicines information,
and scanning feature to enter medications on the list. In the third
round, brand drug name, inclusion of a picture of the pill, name
of the prescribing physician, and ability to upload the medication
list from the pharmacy records were the items that achieved
consensus (≥75% agreement; Multimedia Appendix 2).
Items suggested by participants that were included in further
rounds were as follows: ability to upload a medication list from
pharmacy records, which achieved consensus in round 3, and
a speech-to-text feature to produce a medication list that did
not achieve consensus as an essential feature.
Module 2: Medication Reminder
The design and visual appeal of option A (25 points) reached
consensus among experts as the best to display medication
taking reminders (Figure 3). All 3 items achieved consensus in
the first round with experts agreeing that the medication
reminder feature should include the options to report that the
medication was taken, skipped, or postponed to be taken at
another time (Multimedia Appendix 2).
Module 3: Medication Administration Record
No consensus was obtained among experts as to the best design
to present the record of medication administration, but the
calendar format in option D (127 points) was preferred by most
respondents, followed by options B (132 points), C (143 points),
and A (152 points; Figure 4).
The report format showing days missed on a monthly calendar
was the only one that achieved consensus in the first round. The
report format showing days missed on a daily calendar also
achieved consensus in the second round, but experts did not
agree that showing the percent of doses taken would be helpful
for persons with DDs to track medication taking (Multimedia
Appendix 2).
Module 4: Additional Features
A total of 63% (10/16) of additional features assessed reached
consensus for inclusion in a medication management app. In
the first round, experts agreed that the following features should
be part of the app: ability to record known drug allergies, ability
to share medication information from the app with providers
and caregivers, emergency contact list, and prescription refill
reminders (Multimedia Appendix 2). In the second round,
experts agreed that ability to record side effects experienced, a
drug interactions checker, and an overdose warning for
maximum daily dose of as needed medication should be
incorporated in a future app. In the third round, 2 other
additional features reached consensus as highly important:
automatic refill through pharmacies and doctor appointment
reminders through the app. On the basis of expert feedback from
previous rounds, 2 more features were included for assessment
in the third round, but none achieved consensus: gaming system
with rewards for adherent patients and ability to connect with
peers through the app to motivate and share experiences with
the app.
Figure 2. Medication list screenshots ranked from most preferred (lower score) to least preferred (higher score) based on design and visual appeal and
respective scaled scores.
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Figure 3. Medication reminder screenshots ranked from most preferred (lower score) to least preferred (higher score) based on design and visual appeal
and respective scaled scores.
Figure 4. Medication Administration Record screenshots ranked from most preferred (lower score) to least preferred (higher score) based on design
and visual appeal and respective scaled scores.
Finally, the top 3 most important additional features elected by
experts were as follows: automatic refills through pharmacies;
ability to share medication information from the app with
providers; and ability to share medication information from the
app with family, friends, and caregivers. The top 3 least
important features included a link to an official drug information
source, privacy settings and password protection, and
prescription refill reminders.
In total, at the end of the 3 rounds, 27 of the 42 (64%) features
assessed achieved consensus (Multimedia Appendix 2). For 12
out of the 27 (44%) features, unanimous concordance existed
among persons with a DD or caregivers and the entire panel of
experts; for 9 items (33%), concordance was above 75%; and
for 6 items (22%), concordance with the panel was below 68%.
The latter included dosage, indication, a report that showed days
missed on a daily calendar, record/log of side effects
experienced, drug interactions checker, and a picture of the pill
highlighting any markings it may have.
The summary of items achieving consensus, and respective
percent agreement, in each of the 3 rounds is presented in
Multimedia Appendix 3.
Comments From Experts
Overall, comments reflected the importance of apps to be simple,
easy to use, customizable, and not overbearing in the amount
of information they contain. There should be a balance between
including options for individuals to personalize the app to their
needs and including only those most important features to
achieve the goal of improved adherence and greater
independence for young adults with DDs. Respondents
suggested that the app included different information depending
on whether the user was a caregiver or a person with a DD, with
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more complex information being available to the previous and
simpler and supportive information for self-management
provided to the latter. Additionally, the app should have a system
to assess the severity of side effects, provide decision support
on how to manage side effects, and follow-up for evaluation.
Within the medication list feature, experts emphasized the
importance of pictorial representations of the medication taking
times to address low health literacy and suggested that
medications be sorted according to the time of the day. Several
experts suggested that a picture of the pill be included for each
of the medications on the list with the ability to select from all
possible shapes, sizes, colors, and manufacturer name to avoid
confusion. One expert voiced that the screenshots presented too
much information and advocated that end users provide ultimate
feedback. Using speech-to-text functionality to enter medications
on the list was supported by some experts, but discouraged by
others who raised concerns about problems with pronunciation
and inaccuracy of the medication entered. The alternative way
consisting of having the information autopopulate as the user
types in the first few letters of the medication was seen as risky
and prone to errors because of the variety of presentations
available in the market. Finally, experts believed the app should
allow ordering medications from the pharmacy.
With regard to the medication reminder feature, experts
suggested that the reminder delivery mode (eg, audio, vibrate,
flashing screen) vary depending on whether medications were
optional or mandatory and that a sketch of the pill be shown on
the reminder screen. Geotagging reminders to go off when the
person is at home or at work was another idea. Following the
reminder, the app should provide feedback as an audio verbal
and as a sound when patients tap the took option. Experts
discouraged the use of skip as one of the options, because they
believed this word seemed to give permission to be nonadherent.
Rather, it was suggested that not taken or other neutral word be
used. This should be followed by a text message to notify the
caregiver. Several experts commented that the snooze option
should be coupled with a functionality of how long to snooze
the reminder for.
As per the medication administration record feature, comments
that the dashboard (daily, weekly, monthly) should depend on
the number of medications taken daily (many medications,
display daily; few medications, display weekly or monthly)
were made. A display of how the user is doing in terms of
adherence compared with other peers or a gaming reward system
to serve as a motivational effect to promote adherence were also
proposed. The ability to email or export an adherence report
within the app was deemed helpful, as was the ability to record
reasons for missing doses.
A compilation of all the expert remarks is presented in
Multimedia Appendix 4.
Discussion
Principal Findings and Comparison With Prior Work
In this study, we reviewed existing medication management
apps and identified app features that appeared particularly
relevant in supporting independence of young adults who have
DDs during the medication management process. Of the 42
different features assessed, almost 65% achieved consensus for
inclusion in a future medication management app.
The strength of our study is that the panel of experts included
persons with disabilities as well as other stakeholders involved
in their care. The number of experts included was within the
recommended range [43], and we deliberately used high
consensus criteria to ensure that only features that were
considered critical by experts were identified. The list of features
gathered and assessed by experts was similar to those reported
in other studies [33,44-46], lending support to the accuracy of
the features selected.
Within the medication list feature, experts considered
information on how to take the medication and specific aspects
such as dosage and indication essential. It was also important
for experts that the app included ways to facilitate the entry of
a new medication. This is especially critical for individuals with
dexterity or visual impairments, as these are more prone to
problems in task completion [47]. Although some forms of
adding a medication to the list, such as uploading a medication
list directly from the pharmacy records, are difficult to
operationalize, others including scanning the prescription bottles
or including a drug directory that automatically populates several
fields as the user types in the name of the medication are already
found in some of the current medication management apps.
The medication reminder feature, which is ubiquitous among
medication management apps, should have 3 reporting options
in an easy-to-use screen—taken, not taken, or snooze. Previous
studies assessing the experiences of app users reported their
desire to keep apps as simple as possible to make processes
easier [47], including elderly people [48]. Simplicity was a key
aspect highlighted by experts. On a similar note, the preferred
display format of medication doses taken and missed was a
monthly calendar, with doses taken and missed appearing in
different colors for easy visualization.
The top 3 most important additional features selected by experts
were the ability to perform automatic refills through pharmacies,
to share medication information with providers, and to share
medication information with family, friends, and caregivers.
Of all the apps reviewed, only 1—Medisafe—included the
feature to share medication information with caregivers, which
would be of great value for young adults transitioning to
independence. Previous studies demonstrated that involvement
of caregivers through an app gives them a sense of better being
able to monitor and control their child’s condition [44]. This
feature is called Medfriend and it allows caregivers to track in
real-time whether individuals take their medications and to be
notified if they miss it. This feature assumes that users are able
to tap the screen button if the medication is taken or skipped.
Depending on the type and level of disability, some individuals
may not be able to accomplish this task. The Medisafe app was
ranked number 1 in recent quality assessments [33,46].
Currently, a randomized control trial is under way evaluating
the impact of Medisafe on blood pressure control and medication
adherence in the general population [49].
Several safety-related features such as recording side effects
and drug allergies, overdose warning, or checking drug
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interactions also achieved consensus among experts. Specifically
with regard to the latter, a recent study demonstrated that most
of the apps containing a drug interaction checker did not identify
all possible interactions associated with a given medication and
half were unable to detect drug-herbal medication interactions
[50]. Therefore, the accuracy of this feature needs to be ensured
before inclusion in any app.
Additional features that did not achieve consensus, but that were
initially thought to be important for young adults with DDs,
were gamification (earning rewards or prizes for being adherent)
and socialization. Mixed opinions about gamification were also
found in a previous study assessing preferences of users of apps
for cystic fibrosis [51]. However, the same and other studies
reported socialization as a desired feature for users to find
support in peers with the same condition [51,52].
As implications for future app development, participants in this
and other studies emphasized the need for customization options
to meet individual preferences, needs, and goals [51]; this may
be especially relevant for customization for persons with DD
versus their caregivers. More complex informatics systems
integrating electronic medical records and pharmacy records
would allow more advanced features that support independence
of these individuals in the medication management process,
including Web-based symptom reporting, automatic prescription
refills, or sharing the same medication list with all providers.
Incorporating or linking smart technology such as electronic
pill bottles to the app would provide additional invaluable
information to caregivers and providers to deliver better care
to their patients [24].
The methodology used in this study does not provide the depth
of information necessary to fully design an accessible app for
medication management in this population, but it is a first step
toward achieving that goal and provides useful information to
adapt existing apps. Of note, as a result of the variety of levels
of impairment across different disabilities, apps designed to
help in the medication use process may be more applicable to
persons who have mild-to-moderate impairment of cognitive
or physical function, but this aspect would warrant further
research.
Limitations
This study has limitations. First, we selected the screenshots
that we thought were the most different from each other and
included 4 of them in the questionnaire. Many others could have
been selected, yielding different results. However, the
screenshots selected allowed the extraction of key design aspects
to take into account in future app development. Second,
researchers and professionals with an interest in DDs comprised
the largest proportion of the panel of experts, which could have
affected the results. Third, we did not track individual
participation in each round, and this may have prevented input
on items previously removed due to consensus being achieved.
Finally, 1 limitation with the Delphi method is that the
opportunity for experts to elaborate on their choices and produce
a dialogue around controversial topics does not exist. This may
have been partly addressed by the inclusion of free text
comments sections at the end of each module.
Conclusions
Although many mobile apps for medication management exist,
few are specifically designed to support persons with DDs in
the complex medication management process. This study
provides information on the features of a medication
management app that are most important to persons with DDs
and their caregivers that should be taken into account by
researchers, developers, and designers who create apps
specifically designed for this population. Two key findings from
this study are that simplicity is key and that constant
communication between the person with a DD, the caregiver,
and the health care professional through the app is critical.
Future research will require that a medication management app
specifically designed for persons with DDs be developed or an
existing app be adapted to include the features identified in this
study. Further assessment of the impact of using an app on
independence, medication adherence, self-management
behaviors, and health outcomes is critical to guide their future
use, widespread adoption, and, ultimately, financial support by
payers.
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